{"id":115192,"date":"2020-10-28T08:22:39","date_gmt":"2020-10-28T15:22:39","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/10\/uppsala-in-last-preclinical-stage-for-new-car-t-cell-product-for-glioblastoma"},"modified":"2020-10-28T22:11:20","modified_gmt":"2020-10-29T05:11:20","slug":"uppsala-in-last-preclinical-stage-for-new-car-t-cell-product-for-glioblastoma","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/10\/uppsala-in-last-preclinical-stage-for-new-car-t-cell-product-for-glioblastoma","title":{"rendered":"Uppsala in Last Preclinical Stage for New CAR T-cell Product for Glioblastoma"},"content":{"rendered":"<p style=\"padding-right: 20px\"><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/uppsala-in-last-preclinical-stage-for-new-car-t-cell-product-for-glioblastoma.jpg\"><\/a><\/p>\n<p>Researchers at Uppsala University, in Sweden, in collaboration with the SciLifeLab Drug Discovery and Development Platform, have taken \u201ca large step forward\u201d in developing a potential CAR T-cell therapy for glioblastoma, an aggressive form of brain cancer that is often difficult to treat.<\/p>\n<p>Their project is now entering the final preclinical stage of development, according to the university. The goal is to start clinical studies within four years.<\/p>\n<p>\u201cExtremely few breakthroughs have been made around treating Glioblastoma,\u201d Magnus Essand, professor of gene therapy at Uppsala, said in a press release.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Researchers at Uppsala University, in Sweden, in collaboration with the SciLifeLab Drug Discovery and Development Platform, have taken \u201ca large step forward\u201d in developing a potential CAR T-cell therapy for glioblastoma, an aggressive form of brain cancer that is often difficult to treat. Their project is now entering the final preclinical stage of development, according [\u2026]<\/p>\n","protected":false},"author":575,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-115192","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/115192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/575"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=115192"}],"version-history":[{"count":1,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/115192\/revisions"}],"predecessor-version":[{"id":115222,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/115192\/revisions\/115222"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=115192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=115192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=115192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}